Clinical efficacy comparison of metformin and Myo-inositol in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis protocol
Abstract
Condition being studied: Polycystic ovary syndrome; metformin; myo-inositol.METHODS Participant or population: PCOS patients w e r e d i a g n o s e d a c c o r d i n g t o t h e diagnostic criteria of PCOS formulated by ESHRE/ASRM in Rotterdam in 2003.Intervention: The experimental group was treated with metformin.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.